OUR BUSINESS

Business Model and Value Creation aligned to the Six Capitals

OUR BUSINESS

Our Business model demonstrates the six capitals (inputs), enables value-adding activities (outputs) that create, preserve or erode value for our stakeholders (outcomes)

Red blood cells for transfusion
Fresh frozen plasma and Cryoprecipitate for patient use
Hyper-immune and recovered plasma for NBI
Pooled and Apheresis platelets for transfusion Platelet Immunology & Immuno-haematology testing Stem cell collection, processing, cryopreservation & re-infusing services Laboratory testing to facilitate solid organ, stem cell & bone marrow transplants
Molecular research & development

Being cognisant of our material matters, while managing key risks and opportunities and our strategic objectives (iHEALTh) – all underpinned by sound governance

… and ensures our ability to create value in the future